Publications by authors named "Samuel Kozloff"
Discrepancy between computed tomography (CT) and transthoracic echocardiography (TTE) regarding pericardial effusion (PEff) size is common, but there is limited data regarding the correlation between these 2 imaging methods. The aim of this study is to examine the real-world concordance of observed PEff size between CT and TTE. We performed a retrospective analysis of all imaging reports available from 2013 to 2019 and identified patients with a PEff who underwent both a chest CT and TTE within a 24-hour period.
View Article and Find Full Text PDFBackground: The COVID-19 pandemic led to the urgent implementation of telehealth visits in inflammatory bowel disease (IBD) care; however, data assessing feasibility remain limited.
Objectives: We looked to determine the completion rate of telehealth appointments for adults with IBD, as well as to evaluate demographic, clinical, and social predictors of incomplete appointments.
Design: We conducted a retrospective analysis of all patients with IBD who had at least one scheduled telehealth visit at the NYU IBD Center between 1 March 2020 and 31 August 2021, with only the first scheduled telehealth appointment considered.
Demographic predictors of nonHDL-C increase during COVID-19 pandemic stay-at-home period.
Am J Prev Cardiol
December 2021
The onset of the coronavirus 2019 (COVID-19) pandemic prompted unique public health measures including stay-at-home (SAH) orders that provoked altered dietary and exercise patterns and may have affected medication access and use. Although these impacts have the potential to influence lipid levels, little is known of the consequences of COVID-19 SAH on objective atherosclerotic cardiovascular disease (ASCVD) risk factors. We performed a patient-level analysis of the primary measure of atherogenic lipid-associated risk, nonHDL-C during the 2020 SAH period and the same time period in 2019, in patients within a large health system in New York City.
View Article and Find Full Text PDFArticle Synopsis
- Recent studies hint at a potential benefit when combining immune checkpoint inhibitors (ICI) with anticoagulation (AC), but this research analyzed their effects in advanced cancer patients to see if the combination leads to better outcomes.
- The study included 728 cancer patients over a decade, comparing those on AC during ICI treatment with those who weren't, assessing various clinical outcomes like response rates and survival.
- Results showed no significant improvement in treatment efficacy for patients on AC, while they faced a higher risk of bleeding, leading to a conclusion that combining AC with immunotherapy lacks enough supporting evidence for future trials.
Background: Recent research suggests that baseline body mass index (BMI) is associated with response to immunotherapy. In this study, we test the hypothesis that worsening nutritional status prior to the start of immunotherapy, rather than baseline BMI, negatively impacts immunotherapy response.
Methods: We studied 629 patients with advanced cancer who received immune checkpoint blockade at New York University.